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Abstract
Background: Increasingly available multilayered omics data on large populations has opened exciting analytic
opportunities and posed unique challenges to robust estimation of causal effects in the setting of complex disease
phenotypes. The GAW20 Causal Modeling Working Group has applied complementary approaches (eg, Mendelian
randomization, structural equations modeling, Bayesian networks) to discover novel causal effects of genomic and
epigenomic variation on lipid phenotypes, as well as to validate prior findings from observational studies.
Results: Two Mendelian randomization studies have applied novel approaches to instrumental variable selection in
methylation data, identifying bidirectional causal effects of CPT1A and triglycerides, as well as of RNMT and C6orf42,
on high-density lipoprotein cholesterol response to fenofibrate. The CPT1A finding also emerged in a Bayesian
network study. The Mendelian randomization studies have implemented both existing and novel steps to account
for pleiotropic effects, which were independently detected in the GAW20 data via a structural equation modeling
approach. Two studies estimated indirect effects of genomic variation (via DNA methylation and/or correlated
phenotypes) on lipid outcomes of interest. Finally, a novel weighted R2 measure was proposed to complement
other causal inference efforts by controlling for the influence of outlying observations.
Conclusions: The GAW20 contributions illustrate the diversity of possible approaches to causal inference in the
multi-omic context, highlighting the promises and assumptions of each method and the benefits of integrating
both across methods and across omics layers for the most robust and comprehensive insights into disease
processes.
Keywords: Genomics, Epigenomics, Causal inference, Mendelian randomization, Bayesian networks, Structural
equation modeling, Outliers, Variable selection methods
Background
The question of causality—and the distinction between
association and causation—lies at the heart of scientific
inquiry. In genomic research specifically, the principal
focus is on estimating causal effects of DNA sequence
variants on downstream phenotypes, ideally revealing
the underlying biological mechanisms and identifying
novel treatment targets along the way. At first glance,
the task of causal inference in genomics seems trivial: in-
dividual genotype is inherited following Mendel’s laws of
segregation and independent assortment, and stays stable
after conception, obviating such concerns as reverse caus-
ation, confounding (except for population stratification [1]),
or other spurious relationships with the disease phenotype.
Yet most genome-wide association studies (GWAS) to date
have failed to produce solid evidence of causality, and most
statistically significant GWAS findings are often not repli-
cated in other populations [2] or functionally corroborated
by experimental models. The reasons for this failure to pro-
gress from association to causation are manifold, and
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include poor study design and analysis practices, the “win-
ner’s curse [3],” low frequency of disease-causing alleles, in-
adequate representation of diverse populations, epistatic
effects, gene–environment interactions, and various logis-
tical and financial hurdles to conducting rigorous follow-up
investigations. Largely because of these limitations, few
genomic findings to date have resulted in translational
breakthroughs.
The challenge of causal inference is even more daunting
in methylome-wide association studies (MWAS), which in-
terrogate associations between variation in DNA methyla-
tion and disease phenotypes. Although MWAS findings
suffer from some of the same pitfalls as GWAS (eg the
“winner’s curse”), they are additionally vulnerable to reverse
causation and effects of confounding variables, as most of
the epigenome is not heritable [4] and can be influenced by
aging, disease, and a variety of environmental exposures [5].
Furthermore, single-nucleotide polymorphisms (SNPs) lo-
cated in the vicinity of cytosine-phosphate-guanine (CpG)
sites, which account for most of the methylation variance
in the mammalian genome, have robust effects on the
methylation status of the neighboring (cis-) CpG sites [6],
potentially confounding the observed epigenomic associa-
tions with the phenotype.
The GAW20 provided an opportunity to infer causal re-
lations between the genotype, longitudinal measures of
DNA methylation, and metabolic phenotypes, collected in
a large family study of lipid-lowering treatment with feno-
fibrate [7]. In this manuscript, we describe the methodo-
logical approaches taken by members of the GAW20
Causal Modeling Working Group, present the overarching
themes and insights, and situate GAW20 findings within
the broader context of genetic epidemiology research.
Methods
The characteristics of the GAW20 data set, built from the
Genetics of Lipid Lowering Drugs and Diet Network
(GOLDN) study, are described in detail by Aslibekyan and
colleagues [7]. Briefly, the data included epigenome-wide
DNA methylation as ascertained by the Illumina Infinium
Human Methylation 450 K array before and after a 3-week
treatment with fenofibrate, 718,542 SNPs genotyped by the
Affymetrix 6.0 array, phenotypes (plasma lipids and meta-
bolic syndrome), and relevant covariates on 1105 individ-
uals from 188 families. In addition to the real data from
GOLDN participants, the GAW20 release included 200
replicates of simulated posttreatment methylation and
phenotype (namely triglycerides) measurements, which
were described by Province and colleagues [8].
Table 1 summarizes the tools and techniques employed
by the 6 research teams participating in the GAW20 Causal
Modeling Working Group discussion. All teams analyzed
the real data, and Howey and associates [9] additionally
tested their method on the simulated measurements with
prior knowledge of the “answers” (ie, causal variants).
Furthermore, both Jiang and associates [10] and Li and col-
leagues [11] conducted their own simulations to compare
the performance of their methods to their predecessors.
Taking advantage of the unique multi-omic context of
GAW20, all teams integrated both SNP and CpG methyla-
tion data, except for Auerbach and associates, (Auerbach
J, Hsu Y, Zhou W, Lo SH: Resistant R-squared for sum-
marizing genetic effects. In preparation) who restricted
their analysis to the DNA sequence variation. The team
approaches represented a combination of agnostic (ex-
ploratory), genome-wide tests [11] and validation of prior
reported associations (confirmatory) by using, for ex-
ample, Mendelian randomization (MR) [10, 12], causal
networks [9], structural equations modeling (SEM [13]),
or a novel R2 measure that moderates the influence of out-
liers. Although most teams operated within established
methodologic paradigms (eg, MR or SEM) [9, 10, 12, 13],
Auerbach and associates and Li and colleagues [11] cre-
ated new tools and tested their performance in the
GAW20 data. On balance, the 6 teams varied considerably
in their perspectives, approaches, and results, as discussed
in further detail in the following sections.
Results
Motivation
The contributions from the Causal Modeling Working
Group reflected considerable conceptual diversity. Broadly
Table 1 Summary of statistical methods used by the GAW20 Causal Modeling Group
Auerbach (R2) Howey (Bayesian networks) Jiang (MR) Justice (SEM) Li (Mechanistic
modeling)
Sayols-Baixeras (MR)
Adjustment for family relatedness X X X X X
Bootstrapping X X
Mendelian randomization X X
Principal components X X X
Causal networks X X
Imputed SNPs X
Optimization X X
MR Mendelian randomization, SEM structural equations modeling
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speaking, the teams aimed to strengthen the inferences
that arise from observational studies reporting associa-
tions between DNA sequence or methylation variation
and lipid phenotypes. In the case of Auerbach and associ-
ates, who only interrogated the genetic contribution to the
phenotype, the team aimed to develop a novel R2 measure
that would be robust to outliers. The remaining 5 studies
also considered effects of epigenomic variation, which was
the primary focus of the 2 MR studies [10, 12] that used
genotype as the instrumental variable for methylation,
phenotype, or both. In contrast to using genotype as a
mere instrument, the studies by Li and colleagues [11]
and Justice and associates [13] focused on sequence vari-
ation as the exposure, testing whether the total effect of
the SNP on the phenotype also includes indirect effects
mediated by neighboring CpG methylation or correlated
lipid phenotypes. Finally, Howey and associates [9] sought
to identify possible causal relationships between and
within both omic layers and the phenotypes with the use
of Bayesian networks. Overall, the GAW20 experience
highlighted the utility of integrating across types of omic
data to (a) aid causal inference and (b) paint a more
complete and accurate picture of human lipid variation.
Defining causality in GAW20
Historically, causality has been defined under 1 of 2
main frameworks, commonly referred to by their most
distinctive features: potential outcomes [14] and directed
graphs [15]. Both paradigms were represented among
the 6 GAW20 research teams. The potential outcomes
framework treats randomized controlled experiments as
the gold standard for estimating causal relationships.
Randomization avoids complications that occur when
the manner in which subjects are assigned a treatment
(or subject to an exposure) accounts for the differences
in outcomes in addition to the treatment (or exposure)
itself. That is not to say randomization is a statistical
panacea; Auerbach and associates showed how causal es-
timates may be sensitive to selection effects even when
treatments are randomized. Nevertheless, randomization
eliminates many of the sources of confounding that
could create spurious relationships and biased effect es-
timation. The MR approaches implemented by Jiang and
colleagues [10] and Sayols-Baixeras and associates [12]
represent an extension of this framework to quasiexperi-
mental design via instrumental variable analysis [16].
In contrast, the directed graphs framework relies on
deterministic laws of science for describing causal rela-
tionships. It follows that complete knowledge of the
underlying mechanism of a phenomenon reveals any
cause and effect relationships. In practice, it is often im-
possible to account for every possible relationship that
might exist between a set of variables. Directed graphs
take advantage of probability distributions and
sequential events in time or space to simplify
characterization of the data generating process. Li and
associates [11] used mechanistic modeling to explain
how genetic factors influence phenotype, taking advan-
tage of the fact that genetic factors precede the pheno-
type. Use of structural equations to describe an
outcome, represented in GAW20 by Justice and associ-
ates [13], has its origins in path diagrams [17]. The
power of the directed graph framework lies in its ability
to depict complicated relationships. In GAW20, Howey
and associates [9] represented this framework with a
Bayesian network, which consists of a directed acyclic
graph and a set of parameters in all conditional probabil-
ity distributions. Although this procedure is computa-
tionally expensive, it allows simultaneous analytic
consideration of a large number of possible mechanisms.
Even though the interpretations of causality varied within
the Causal Modeling Working Group, the teams came to
the consensus definition of causal inference as the process
that evaluates (and potentially rules out) competing expla-
nations for observed associations between exposures (eg,
genomic variation) and outcomes (eg, metabolic pheno-
types). All analyses took place in the multi-omic setting of
GAW20 data, which held several causal possibilities as
summarized in Fig. 1, including confounding and reverse
causation scenarios. Additionally, directed acyclic graphs
(Fig. 1) can be expanded to accommodate pleiotropic ef-
fects considered by multiple GAW20 analyses [10, 12, 13].
Similarly, these graphs (Fig. 1a-h) can be modified to in-
clude repeated measurements of both methylation and
phenotypic data, adding fenofibrate treatment and/or base-
line lipid concentrations as potential nodes. However, even
though several teams used multiple lipid measurements in
their analyses, longitudinal dynamics were not a major
focus of the Causal Modeling Working Group. For ex-
ample, no Causal Modeling Working Group team interro-
gated changes in epigenetic patterns over the treatment
period, likely because of the inextricable confounding be-
tween fenofibrate and batch effects on methylation mea-
surements, described in detail elsewhere [7]. Beyond
GAW20, the question of temporal variation in epigenetic
effects remains similarly unexplored, but an increasing
number of large-scale cohorts are currently in process of
obtaining serial methylation data, promising future oppor-
tunities for adapting current causal inference methods to
longitudinal epigenetics.
Theoretical and practical challenges
Data
The first set of challenges for the Causal Modeling
Working Group was presented by the structure of the
GAW20 data set. The moderate sample size (N = 1105),
particularly by the standards of MR analysis, hampered
detection of statistically significant effects. An important
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step that all teams performed, but that can be often
overlooked, was ensuring that the data was suitable for
analysis through formatting and cleaning, such as check-
ing Hardy-Weinberg equilibrium and/or minor allele
frequencies and handling missing data. All teams
adjusted for covariates (eg, age and sex) in their analyses
to address bias resulting from confounding or the poten-
tial mediating effects of such variables. A special case of
covariate adjustment necessary in GOLDN/GAW20 data
is accounting for family relatedness, which is essential
for producing valid estimates of effect in genetic studies.
That was accomplished by implementing existing
methods accounting for family structure [10–13], ex-
tending such methods, or not accounting for family
structure while observing this limitation [9]. Potential
technical artifacts in the DNA methylation data were ad-
dressed by including principal components in MWAS
analyses [9, 10, 13]. Finally, as outlying observations can
threaten the accuracy of estimating average effects, Au-
erbach and associates derived a weighted R2 measure that
was resistant to such influences and could be used to
strengthen inference from traditional statistics.
Analytic assumptions
The validity of causal effects estimated by all statistical
methods hinges on satisfying the underlying assumptions,
which are not always empirically testable. For example,
MR estimators must meet the general assumptions for
any instrumental variable, which include a robust associ-
ation with the risk factor (testable), no common causes
between the genotype and the phenotype of interest (not
testable, but usually satisfied by random assortment of al-
leles—with the exception of population stratification), and
no pleiotropic effects (ie, the genetic instrumental variable
must only be associated with the phenotype of interest
through the intermediate phenotype that is it meant to
represent; not directly testable). To address the third as-
sumption, Sayols-Baixeras and colleagues [12] used the
widely accepted MR-Egger method [18] to rule out plei-
otropy. In contrast, Jiang and associates [10] developed a
novel method (constrained instrumental variables) that
adaptively selects the optimal subset of instrumental vari-
ables that maximize associations with the intermediate
phenotype of interest while accounting for potential pleio-
tropic effects. The constrained instrumental variables find-
ings were comparable, albeit not identical, to MR-Egger
and two-stage least-squares MR, identifying 2 additional
causal associations as well as the 1 association detected by
established methods. Meanwhile, Justice and associates
[13] justified the concern about pleiotropic effects in the
GAW20 data, reporting independent direct effects of
rs964184 on both triglycerides and high-density lipopro-
tein cholesterol, and thus indicating existence of true
pleiotropy.
Similar problems exist in Bayesian network analyses [9],
requiring that suitable data are included in the analysis to
anchor the correct direction of the causal relationships be-
tween variables of interest. Other assumptions behind
Bayesian networks include acyclic relationships between
variables; multinomial distribution of discrete variables
and normal distribution of continuous variables; inde-
pendence between variables conditional on their parents;
and no parents for SNP variables. Of those, the normality
assumption is the most problematic as genomic variation
is coded as 0/1/2, but is still modeled continuously to
avoid problems posed by low minor allele frequencies.
The SEM analysis by Justice and colleagues [13] as-
sumes that all data are missing at random, which is espe-
cially unlikely in longitudinal data. Justice and associates
[13] found no association between missingness and any
informative variable in the data set (eg, sex, age, metabolic
syndrome status). However, the GAW20 data set does not
contain all potentially relevant confounders that may be
Fig. 1 Possible (nonexhaustive) causal structures of the GAW20 data.
Directed acyclic graphs illustrating several causal scenarios possible
in the GAW20 data: (a) and (b) represent direct effects of DNA
sequence variation and DNA methylation on lipids, respectively; (c)
represents a direct effect of lipids on DNA methylation; (d) and (e)
represent full mediation scenarios, in which the effect of DNA
sequence variation on lipids/DNA methylation occurs solely through
DNA methylation/lipids, respectively; (f) shows confounding of the
DNA methylation–lipids relationship by DNA sequence variation; (g)
and (h) depict partial mediation scenarios, in which DNA sequence
variation affects lipids/DNA methylation both directly and through
DNA methylation/lipids, respectively
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predictive of missingness; consequently, the missing at
random assumption may not be valid.
The likelihood inference proposal for indirect estima-
tion (LIPID) developed by Li and colleagues [11] focuses
on the CpG sites that are regulated by neighboring DNA
sequence variants (methylation quantitative trait loci),
and also have a causal effect on the phenotype. However,
current estimates indicate methylation quantitative trait
loci regulation at < 40% of CpG sites [19], limiting the
applicability of LIPID in studies of DNA methylation.
Additionally, prior MR studies of lipids [20] demon-
strated effects of the phenotype on CpG methylation ra-
ther than vice versa (ie, in the direction assumed by
LIPID). Although the GAW20 findings are consistent
with either direction of effect (methylation ➔ lipids and
lipids ➔ methylation) [9, 12], only one direction satisfies
the analytic assumption of the LIPID method.
Furthermore, both Li and colleagues [11] and Auer-
bach and colleagues adjusted for familial relatedness in
the GAW20 data using the theoretical kinship matrix,
which assumes that the founder populations are com-
pletely unrelated (which is unlikely in the context of hu-
man population history [21], particularly in close-knit
communities of Utah and Minnesota that served as the
study base for GOLDN/GAW20) as well as correctly
specified. These issues could be obviated by estimating
kinship based on SNP data rather than self-reported
pedigree information [21]. The methods implemented by
Li and associates [11] and Auerbach and associates also
assume independence of study participants conditional
on their genotype. Because environmental variables
within a household are likely to be correlated, this as-
sumption likely does not hold, and merits further inves-
tigation with a fuller data set that includes such factors
as diet, lifestyle, and other potential nongenetic effects.
Finally, as all teams used linear regression models,
all methods used in the Causal Modeling Working
Group are based on the standard assumptions of
error independence, homoscedasticity, and multivari-
ate normality, as well as a linear relationship between
the genetic/epigenetic variants and phenotypes that is
unlikely to completely capture the underlying biologic
complexity.
Subjective choices
Related to the issue of methodologic assumptions, many
of the analyses used by teams required some form of
subjective choices, such as weighted covariance matrix,
the size of methylation probe sets [10] or SNP windows
[10, 12], Bayesian network variables [9], and imputation
parameters [10]. Future studies are warranted to exam-
ine the sensitivity of the proposed methods to such arbi-
trary initial conditions.
Computation
All analyses performed by the Causal Modeling Working
Group faced a number of computation challenges, in-
cluded but not limited to bootstrapping [9, 10], imput-
ation [10], optimization algorithms [9], and parallelization
of analyses (all teams).
Discussion
The multilayered data environment provided by GAW20
was suitable for numerous avenues of causal inquiry,
spurring vastly different approaches that unsurprisingly
produced different results. One exception to that pattern
was the effect of triglycerides on methylation loci in
CPT1A, captured by both MR (in GAW20 and else-
where [20]) and Bayesian networks, with the latter esti-
mating the likelihood of such a causal association at 58%
[9]. Notably, in addition to replicating the effect of lipids
on CPT1A methylation, Sayols-Baixeras and associates
[12] also showed that the reverse effect (ie, from methy-
lation to triglycerides) cannot be ruled out. This is con-
sistent with the estimate from the Bayesian network
analysis, in which probability values near 50% indicate
that the causal relationship is equally likely to be in ei-
ther direction.
The convergence of the 2 distinct approaches on the
same finding showed that the potential outcomes and
the directed acyclic graph paradigms are not irreconcil-
able. Indeed, researchers have identified a variety of con-
ditions necessary to bridge the 2 frameworks [15, 22,
23]. However, as a consequence of the complexity of
causal inference, a variety of strategies are still useful for
identifying causal relationships. In GAW20, the investi-
gation of the CPT1A methylation➔ triglyceride relation-
ship was hindered by the lack of a strong genetic
instrument for the methylation loci. However, future ap-
plications of novel variable selection methods such as
constrained instrumental variables [10] may be able to
provide strong instruments for bidirectional MR analyses
to further interrogate this epigenetic finding. Conversely,
findings of causal effects of methylation in RNMT and
C6orf42 on high-density lipoprotein cholesterol response
to fenofibrate reported by Jiang and associates [10] were
subsequently bidirectionally reanalyzed to rule out re-
verse causality; the resulting evidence did not support a
causal effect of high-density lipoprotein changes on
DNA methylation. Another impediment to considering
all possible causal pathways was posed by the insufficient
sample size. For example, Justice and associates [13] only
modeled the mediating effect of methylation on the
pathway between SNP and triglyceride, because a SEM
analysis examining a larger number of possible scenar-
ios—including one where lipids act as mediators of the
SNP–methylation relationship—would have been under-
powered in the GAW20 data set.
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Although most analyses undertook a candidate gene
approach, aiming to strengthen causal inference for
already known loci, Li and associates [11] used their
LIPID method to identify novel genes implicated in lipid
metabolism. Of 13,968 considered genes, they identified
FAT1 and DCTN6 as having a significant effect on trigly-
ceride phenotypes. These 2 genes were not among those
examined in the other analyses of the Causal Modeling
Working Group, which precludes direct comparisons
with other integrative methods, such as with the struc-
tural equations models implemented by Justice and col-
leagues [13]. However, both FAT1 and DCTN6 are
biologically plausible, and are annotated to lipid metab-
olism in the Database for Annotation, Visualization, and
Integrated Discovery database [11]. Furthermore, in a rat
model of in utero undernutrition followed by leptin
treatment, Dctn6 emerged as a target for “thrifty” meta-
bolic programming [24], demonstrating its epigenetic
connection to metabolic phenotypes. Given the compu-
tational efficiency of the LIPID method and its demon-
strated superior statistical power compared to existing
methods [11], these findings illustrate the promise of
this approach for gene discovery in future integrative
analyses of SNP/CpG methylation data.
Conclusions
The experience of the GAW20 Causal Modeling Work-
ing Group illustrated several challenges and promises of
causal inference in the multi-omic data environment.
Employing diverse strategies to identify novel causal
genes or validate prior observational findings, GAW20
contributions showed that there is no statistical “silver
bullet,” as each method is predicated on its own—often
not directly verifiable—assumptions. Because true causal
findings are likely to be detected by more than one algo-
rithm, future causal inference approaches can benefit
from integrating multiple methods with complementary
strengths and limitations. Moreover, as the availability of
omics data on large population increases exponentially,
it is imperative that future efforts continue exploring
novel ways of leveraging all available omics layers for ro-
bust causal inference, as well as increasingly more accur-
ate modeling of complex trait etiology.
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